Invacare Corporation Reports Expected Impact of Medical Device Excise Tax Based on IRS Final Rule

The Internal Revenue Service today issued final regulations on the 2.3% excise tax on medical devices that is part of the Affordable Care Act. Invacare Corporation has reviewed the final regulations and believes that most of its products will be exempt from the tax based on the retail exemption provided in the regulations. Invacare believes that certain products that it sells for institutional use will be subject to the excise tax. Based on its interpretation of the regulations, the Company expects that the impact from the tax when it first takes effect in 2013 will be less than $1.5 million; and it intends to pass it on to the market. Invacare Corporation , headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The Company has 6,200 associates and markets its products in approximately 80 countries around the world.